A Multicenter Prospective Study of "High Risk" Molecular Typing in Patients With Adult T Lymphoblastic Lymphoma

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

NCT07270861 ·Status: RECRUITING

Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors

NCT05223231 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

NCT05661955 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Low-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy Failure

NCT05547282 ·Status: UNKNOWN ·Phase: NA

Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients

NCT03925896 ·Status: UNKNOWN ·Phase: PHASE1

Study Investigating Safety, Tolerability, Pharmacokinetics (PK) and Antitumor Activities of Anti-PD-1 (Programmed Death-1) Monoclonal Antibody

NCT04068519 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

NCT07203352 ·Status: RECRUITING ·Phase: PHASE3

A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

NCT01462903 ·Status: UNKNOWN ·Phase: PHASE1

A Study of TFX05-01 in Patients With Advanced Solid Tumors

NCT05434299 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest.

NCT05044728 ·Status: UNKNOWN ·Phase: PHASE2

Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma

NCT01667302 ·Status: UNKNOWN ·Phase: PHASE2

A Phase II Study of Nasal NK/T-cell Lymphoma

NCT00292695 ·Status: COMPLETED ·Phase: PHASE2

Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases

NCT05129202 ·Status: COMPLETED

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer

NCT05160545 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

NCT05170958 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

NCT04321330 ·Status: COMPLETED ·Phase: PHASE2

Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer

NCT06519669 ·Status: TERMINATED ·Phase: NA

A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

NCT05779163 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

L-TIL in Patients With Malignancy Resistance to Anti-PD-1 Therapy

NCT04268108 ·Status: UNKNOWN

Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients

NCT03079544 ·Status: COMPLETED

A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.

NCT05877924 ·Status: RECRUITING ·Phase: PHASE1

Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors

NCT04126590 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors

NCT05729399 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC

NCT07052669 ·Status: RECRUITING ·Phase: PHASE3

Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC

NCT04324125 ·Status: RECRUITING